A Study of OROS Hydromorphone HCL vs Morphine in Cancer Pain Patients.
Status:
Completed
Trial end date:
2001-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to demonstrate the clinical equivalence of hydromorphone and
morphine (immediate-release [IR] and sustained-release [SR] formulations) using the "worst
pain in the past 24 hours" item of the Brief Pain Inventory (BPI). The secondary objective of
this study was to compare hydromorphone and morphine in the following variables: other pain
measures, various questionnaires, and safety and tolerability variables.